Latest

age related macular degeneration

This shows a pair of eye glasses next to an ashtray, symbolizing the connection between smoking and AMD.

Featured Genetics Neuroscience Visual Neuroscience

·February 27, 2026·9 min read

Cigarette Smoke Triggers Epigenetic Age Acceleration in the Eyes

Cigarette smoke doesn't just damage eye cells; it causes epigenetic shifts that "lock" the genes needed to prevent blindness and macular degeneration.

Featured Neuroscience Visual Neuroscience

·October 20, 2025·10 min read

Electronic Eye Implant Restores Reading Vision in AMD

A groundbreaking European trial has shown that a new electronic eye implant, paired with augmented-reality glasses, can restore reading vision to patients blinded by geographic atrophy from dry age-related macular degeneration (AMD). The device, called the PRIMA System, enabled 84% of participants to read letters, numbers, and words through previously sightless eyes.

Featured Genetics Neuroscience Visual Neuroscience

·September 26, 2025·5 min read

mRNA Vaccine Targets Vision Loss in AMD

A new mRNA vaccine developed in Japan has been shown to suppress abnormal blood vessel growth in the retina of mice, offering hope for patients with age-related macular degeneration (AMD). Current treatments require repeated injections directly into the eye, but this vaccine can be delivered intramuscularly, making it less invasive and easier to administer.

Featured Genetics Neuroscience Visual Neuroscience

·September 23, 2025·4 min read

Human Stem Cell Transplants Boost Vision in Advanced Dry AMD

A new clinical trial suggests stem cell therapy may restore vision in people with advanced dry age-related macular degeneration, a disease that currently has no cure. Researchers transplanted retinal pigment epithelial stem cells, derived from adult postmortem eye tissue, into patients’ eyes.

Featured Genetics Neuroscience Visual Neuroscience

·July 18, 2025·3 min read

Innovative Therapies Help Restore Vision Loss in Macular Degeneration

Age-related macular degeneration (AMD) remains a leading cause of vision loss, but new therapies are reshaping its treatment. Recently approved drugs, pegcetacoplan and avacincaptad pegol, target the complement system to slow dry AMD progression.

Brain Cancer Featured Neuroscience Visual Neuroscience

·July 14, 2025·4 min read

Cancer Drug Shows Promise In Treating AMD Vision Loss

Scientists have discovered that a locally developed cancer drug, PRL3-zumab, may offer a groundbreaking treatment for two major causes of blindness: wet age-related macular degeneration and diabetic retinopathy. Pre-clinical studies showed that intravenous PRL3-zumab reduced abnormal eye blood vessel leakage by 86% more than standard eye injections, with fewer risks.

Featured Genetics Neuroscience Visual Neuroscience

·June 24, 2025·7 min read

Could This Molecule Prevent Vision Loss in AMD?

A new study reveals that increasing levels of apolipoprotein M (ApoM) may slow or prevent the progression of age-related macular degeneration (AMD), a major cause of blindness in older adults. Researchers found that low ApoM impairs cholesterol metabolism in the retina, contributing to inflammation and vision loss—especially in advanced forms like geographic atrophy.

Featured Neuroscience Visual Neuroscience

·June 10, 2025·2 min read

Sticky Molecules May Hold the Key to Preventing Vision Loss in AMD

A new study reveals how sticky molecules called heparan sulfate (HS) may trap lipoproteins in the eye and trigger early age-related macular degeneration (AMD). These fat-protein particles, similar to HDL, accumulate between retinal layers, forming drusen that damage vision over time.

Featured Neuroscience Visual Neuroscience

·May 23, 2025·4 min read

Eye Surgery Technique Could Restore Vision in Macular Degeneration

Scientists have developed a novel surgical method allowing two retinal tissue grafts to be implanted in a single eye, advancing treatment strategies for dry age-related macular degeneration (AMD). This new approach enables side-by-side testing of grafts—one with retinal pigment epithelial (RPE) cells and one without—within the same lesion, using a specially designed clamp to maintain eye pressure and reduce damage.

Featured Neuroscience Visual Neuroscience

·April 22, 2025·4 min read

Rewiring Retinal Messages to Slow Vision Loss in AMD

Age-related macular degeneration (AMD), the leading cause of adult blindness, affects nearly half of Oklahomans over age 80. New research is uncovering how retinal cells communicate using microRNA and extracellular vesicles (EVs), with the goal of slowing AMD progression.

Featured Neuroscience Visual Neuroscience

·April 17, 2025·6 min read

Gold Nanoparticles Restore Vision in Macular Degeneration

A new study shows that gold nanoparticles injected into the retina can restore vision in mice with retinal degeneration, offering a less invasive alternative to current retinal prostheses. When activated by patterned infrared light, these nanoparticles stimulate retinal cells, bypassing damaged photoreceptors.

Featured Neuroscience Visual Neuroscience

·December 4, 2024·4 min read

Sleep Apnea May Increase Risk of Wet Macular Degeneration

A new study has linked moderate-to-severe obstructive sleep apnea (OSA), characterized by low oxygen levels overnight, with an increased risk of developing wet age-related macular degeneration (AMD). The research suggests nocturnal hypoxia could affect the oxygen-sensitive retina, contributing to AMD progression.